Development, Characterization, and Reversal of Acquired Resistance to the MEK1 Inhibitor Selumetinib (AZD6244) in an In Vivo Model of Childhood Astrocytoma

PURPOSE: The BT-40 low-grade childhood astrocytoma xenograft model expresses mutated BRAF(V600E) and is highly sensitive to the MEK inhibitor selumetinib (AZD6244). In this study we developed and characterized selumetinib resistance and explored approaches to circumventing the mechanism(s) of acquir...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bid, Hemant K., Kibler, Aaron, Phelps, Doris A., Manap, Sagymbek, Xiao, Linlin, Lin, Jiayuh, Capper, David, Oswald, Duane, Geier, Brian, DeWire, Mariko, Smith, Paul D., Kurmasheva, Raushan T., Mo, Xiaokui, Fernandez, Soledad, Houghton, Peter J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086218/
https://ncbi.nlm.nih.gov/pubmed/24132923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0842
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados